Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C5F12 |
| Molecular Weight | 288.0343 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
FC(F)(F)C(F)(F)C(F)(C(F)(F)F)C(F)(F)F
InChI
InChIKey=MPEFSWGYIJNMCW-UHFFFAOYSA-N
InChI=1S/C5F12/c6-1(3(9,10)11,4(12,13)14)2(7,8)5(15,16)17
| Molecular Formula | C5F12 |
| Molecular Weight | 288.0343 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Perflisopent is the fluorocarbon agents that make myocardial contrast echocardiography possible with venous injection. It provides prolonged contrast for myocardial contrast echocardiography via peripheral venous administration, although the hemodynamic parameters deteriorate at high doses. It had been in phase III for the diagnostic of cardiovascular disorders. However, this development was discontinued.
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Comparison of power Doppler and B-scan sonography for renal imaging using a sonographic contrast agent. | 1998-12 |
|
| Administration of an intravenous perfluorocarbon contrast agent improves echocardiographic determination of left ventricular volumes and ejection fraction: comparison with cine magnetic resonance imaging. | 1998-11 |
|
| Conventional and hypobaric activation of an ultrasound contrast agent. | 1998-10 |
|
| Phase III multicenter trial comparing the efficacy of 2% dodecafluoropentane emulsion (EchoGen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents in patients with suboptimal echocardiograms. | 1998-07 |
|
| Prolonged myocardial contrast echocardiography via peripheral venous administration of QW3600 injection (EchoGen): its efficacy and side effects. | 1997-01-01 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9046489
Single doses of 0.1, 0.2, 0.5, and 0.8 ml/kg
Route of Administration:
Intravenous
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:12:45 GMT 2025
by
admin
on
Mon Mar 31 18:12:45 GMT 2025
|
| Record UNII |
40FAQ8ON24
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
GG-108B
Created by
admin on Mon Mar 31 18:12:45 GMT 2025 , Edited by admin on Mon Mar 31 18:12:45 GMT 2025
|
PRIMARY | |||
|
CHEMBL2107082
Created by
admin on Mon Mar 31 18:12:45 GMT 2025 , Edited by admin on Mon Mar 31 18:12:45 GMT 2025
|
PRIMARY | |||
|
40FAQ8ON24
Created by
admin on Mon Mar 31 18:12:45 GMT 2025 , Edited by admin on Mon Mar 31 18:12:45 GMT 2025
|
PRIMARY | |||
|
100000082729
Created by
admin on Mon Mar 31 18:12:45 GMT 2025 , Edited by admin on Mon Mar 31 18:12:45 GMT 2025
|
PRIMARY | |||
|
SUB09719MIG
Created by
admin on Mon Mar 31 18:12:45 GMT 2025 , Edited by admin on Mon Mar 31 18:12:45 GMT 2025
|
PRIMARY | |||
|
11679
Created by
admin on Mon Mar 31 18:12:45 GMT 2025 , Edited by admin on Mon Mar 31 18:12:45 GMT 2025
|
PRIMARY | |||
|
C166708
Created by
admin on Mon Mar 31 18:12:45 GMT 2025 , Edited by admin on Mon Mar 31 18:12:45 GMT 2025
|
PRIMARY | |||
|
7529
Created by
admin on Mon Mar 31 18:12:45 GMT 2025 , Edited by admin on Mon Mar 31 18:12:45 GMT 2025
|
PRIMARY | |||
|
DTXSID9074721
Created by
admin on Mon Mar 31 18:12:45 GMT 2025 , Edited by admin on Mon Mar 31 18:12:45 GMT 2025
|
PRIMARY | |||
|
594-91-2
Created by
admin on Mon Mar 31 18:12:45 GMT 2025 , Edited by admin on Mon Mar 31 18:12:45 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |